Benzonatate
Product Images NDC 66116-513

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 66116-513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure For Benzonatate (Edde25d4 9ac3 4b11 8b65 Be221e06f37e 01)

Chemical structure of benzonatate showing the arrangement of its atoms and bonds, including its molecular formula C30H53NO11.*

FDA Label Image

Benzonatate Capsules Usp 200mg #30 (Edde25d4 9ac3 4b11 8b65 Be221e06f37e 02)

Label for MedStart Connect Benzonatate Capsules, USP 200 mg, containing 30 capsules. The label indicates the product is Rx only, a sample not for sale, and provides storage instructions to store at controlled room temperature (20°-25°C or 68°-77°F). It includes directions to see the package insert for dosage, a toll-free number for medication inquiries, and manufacturer information for Banner Pharmacaps Inc., with distribution by MedVantx, Inc. and Teva Pharmaceuticals USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.